Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 Oct 27;7(1):25.
doi: 10.1186/1939-4551-7-25. eCollection 2014.

ICON: chronic rhinosinusitis

Claus Bachert  1 , Ruby Pawankar  2 , Luo Zhang  3 , Chaweewan Bunnag  4 , Wytske J Fokkens  5 , Daniel L Hamilos  6 , Orathai Jirapongsananuruk  4 , Robert Kern  7 , Eli O Meltzer  8 , Joaquim Mullol  9 , Robert Naclerio  10 , Renata Pilan  11 , Chae-Seo Rhee  12 , Harumi Suzaki  13 , Richard Voegels  14 , Michael Blaiss  15
Affiliations

ICON: chronic rhinosinusitis

Claus Bachert et al. World Allergy Organ J. .

Abstract

Chronic rhinosinusitis (CRS) is a public health problem that has a significant socio-economic impact. Moreover, the complexity of this disease due to its heterogeneous nature based on the underlying pathophysiology - leading to different disease variants - further complicates our understanding and directions for the most appropriate targeted treatment strategies. Several International/national guidelines/position papers and/or consensus documents are available that present the current knowledge and treatment strategies for CRS. Yet there are many challenges to the management of CRS especially in the case of the more severe and refractory forms of disease. Therefore, the International Collaboration in Asthma, Allergy and Immunology (iCAALL), a collaboration between EAACI, AAAAI, ACAAI, and WAO, has decided to propose an International Consensus (ICON) on Chronic Rhinosinusitis. The purpose of this ICON on CRS is to highlight the key common messages from the existing guidelines, the differences in recommendations as well as the gaps in our current knowledge of CRS, thus providing a concise reference. In this document we discuss the definition of the disease, its relevance, pharmacoeconomics, pathophysiology, phenotypes and endotypes, genetics and risk factors, natural history and co-morbidities as well as clinical manifestations and treatment options in both adults and children comprising pharmacotherapy, surgical interventions and more recent biological approaches. Finally, we have also highlighted the unmet needs that wait to be addressed through future research.

Keywords: Biologicals; Chronic rhinosinusitis; Co-morbidities; Genetics; Pathophysiology; Pharmacoeconomics; Phenotypes; Treatment; Unmet needs.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Prevalence of CRS. The GA2LEN study. Reported prevalence of CRS throughout Europe [9]).
Figure 2
Figure 2
Pathomechanisms of CRS. A. CRSwNP. In a TH2-type microenvironment with general lack of regulatory T (Treg) cell function, IL-5 induces eosinophilia, and IL-4 and IL-13 induce local IgE production. An alternatively activated macrophage subset contributes to the inflammation. The activation of epithelium colonized by bacteria and fungi leads to release of proinflammatory chemokines and cytokines with increased thymic stromal lymphopoietin (TSLP) and IL-32 levels. Activated epithelial cells die, with apoptosis resulting in a compromised epithelial barrier. B. CRSsNP. Instead of a TH2-skewed T-cell response, a TH1 or a mixed TH0 response predominates, neutrophilia is often associated, and expression of TGF-β and its receptors is increased. DC, Dendritic cell. This figure is reused with permission from the Journal of Allergy and Clinical Immunology [198].
Figure 3
Figure 3
"Pheno- and endotype" CRS. Pheno- and endotyping of CRS based on the recently published findings on asthma comorbidity and recurrence after surgery (Ghent classification of CRS).
See this image and copyright information in PMC

References

    1. Meltzer EO, Hamilos DL, Hadley JA, Lanza DC, Marple BF, Nicklas RA, Bachert C, Baraniuk J, Baroody F, Benninger M, Brook I, Chowdhury B, Druce H, Durham S, Ferguson B, Gwaltney J, Jr, Kaliner M, Kennedy D, Lund V, Naclerio R, Pawankar R, Piccirillo J, Rohan P, Simon R, Slavin R, Togias A, Wald E, Zinreich S. Rhinosinusitis: establishing definitions for clinical research and patient care. J Allergy Clin Immunol. 2004;114(6 Suppl):155–212. doi: 10.1016/j.jaci.2004.09.029. - DOI - PMC - PubMed
    1. Slavin RG, Spector SL, Bernstein IL, Kaliner MA, Kennedy DW, Virant FS, Wald ER, Khan DA, Blessing-Moore J, Lang DM, Nicklas RA, Oppenheimer JJ, Portnoy JM, Schuller DE, Tilles SA, Borish L, Nathan RA, Smart BA, Vandewalker ML, American Academy of Allergy, Asthma and Immunology; American College of Allergy, Asthma and Immunology; Joint Council of Allergy, Asthma and Immunology The diagnosis and management of sinusitis: a practice parameter update. J Allergy Clin Immunol. 2005;116(6 Suppl):S13–S47. doi: 10.1016/j.jaci.2005.09.048. - DOI - PubMed
    1. Rosenfeld RM. Clinical practice guideline on adult sinusitis. Otolaryngol Head Neck Surg. 2007;137(3):365–377. doi: 10.1016/j.otohns.2007.07.021. - DOI - PubMed
    1. Desrosiers M, Evans GA, Keith PK, Wright ED, Kaplan A, Bouchard J, Ciavarella A, Doyle PW, Javer AR, Leith ES, Mukherji A, Robert Schellenberg R, Small P, Witterick IJ. Canadian clinical practice guidelines for acute and chronic rhinosinusitis. J Otolaryngol Head Neck Surg. 2011;40(Suppl 2):S99–S193. - PubMed
    1. Fokkens WJ, Lund VJ, Mullol J, Bachert C, Alobid I, Baroody F, Cohen N, Cervin A, Douglas R, Gevaert P, Georgalas C, Goossens H, Harvey R, Hellings P, Hopkins C, Jones N, Joos G, Kalogjera L, Kern B, Kowalski M, Price D, Riechelmann H, Schlosser R, Senior B, Thomas M, Toskala E, Voegels R, Wang De Y, Wormald PJ. European Position Paper on Rhinosinusitis and Nasal Polyps 2012. Rhinology 2012 Suppl. 2012;23:1–298. - PubMed